Classification Term: 3264

Acylphloroglucinols and derivatives (ontology term: CHEMONTID:0002519)

Phloroglucinol derivatives characterized by the presence of a COR group." [DOI:10.1080/08927022.2012.700483]

found 2 associated metabolites at family metabolite taxonomy ontology rank level.

Ancestor: Phloroglucinols and derivatives

Child Taxonomies: There is no child term of current ontology term.

2,4,6-trihydroxybenzaldehyde

2,4,6-Trihydroxybenzaldehyde

C7H6O4 (154.0266076)


2,4,6-trihydroxybenzaldehyde is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1λ⁴-chromen-1-ylium. It is generated by unspecified-gutmicro enzyme via an anthocyanidin-c-ring-fission-pattern3 reaction. This anthocyanidin-c-ring-fission-pattern3 occurs in human gut microbiota. 2,4,6-Trihydroxybenzaldehyde is an orally active NF-?B inhibitor. 2,4,6-Trihydroxybenzaldehyde shows anti-tumor activity, anti-cancer cell proliferative activity and anti-obesity activity. 2,4,6-Trihydroxybenzaldehyde. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=487-70-7 (retrieved 2024-09-18) (CAS RN: 487-70-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Antibiotic GR 95647X

2,4,6-trihydroxy-5-(1-{5-hydroxy-1,1,3-trimethyl-decahydrocyclopropa[e]inden-3-yl}-3-methylbutyl)benzene-1,3-dicarbaldehyde

C26H36O6 (444.2511756)


Antibiotic GR 95647X is a constituent of Eucalyptus globulus (Tasmanian blue gum). Constituent of Eucalyptus globulus (Tasmanian blue gum).